Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
J&J to Restore Full Access to Doxil Cancer Drug
FOX Business
Tue, 10/16/12 - 10:50 am
Tags:
JNJ
,
Doxil
,
cancer
,
drug shortages
J&J’s Third-Quarter Profit Beats Estimates on Drug Sales
Bloomberg
Tue, 10/16/12 - 09:25 am
Tags:
earnings
,
JNJ
5 Top Pharmaceuticals Paying Substantial Dividends
Seeking Alpha
Sun, 10/14/12 - 11:19 am
Tags:
Bristol-Myers Squibb
,
JNJ
,
Eli Lilly
,
Pfizer
,
Merck
Johnson & Johnson Third Quarter Earnings Sneak Peek
Wall St Cheat Street
Sat, 10/13/12 - 12:28 pm
Tags:
JNJ
,
earnings
Is a VIVUS Buyout Still on the Table? And if So, by Whom?
Motley Fool
Fri, 10/12/12 - 11:02 am
Tags:
Vivus
,
M&A
,
Bristol-Myers Squibb
,
Merck
,
JNJ
,
Arena Pharmaceuticals
Is Alzheimer's Research the Next Big Thing in Biotech?
Motley Fool
Thu, 10/11/12 - 10:47 am
Tags:
Alzheimer's disease
,
Eisai
,
Forest Labs
,
JNJ
,
Pfizer
,
Eli Lilly
,
Roche
Johnson & Johnson Slipping Ahead Of Q3 Earnings; Shares At Key Support Level
Seeking Alpha
Thu, 10/11/12 - 10:40 am
Tags:
earnings
,
JNJ
Former Synthes Execs Excluded From Federal Healthcare Programs
Pharmalot
Wed, 10/10/12 - 11:43 am
Tags:
JNJ
,
Synthes
,
Medicare
,
Medicaid
Eli Lilly Sees A Ray Of Hope But The Stock Is Ahead Of Itself
Seeking Alpha
Wed, 10/10/12 - 11:37 am
Tags:
Eli Lilly
,
AstraZeneca
,
GSK
,
JNJ
,
Merck
,
Pfizer
J&J eyes new Doxil process to reverse shortage
Fierce Pharma
Tue, 10/9/12 - 11:16 am
Tags:
Doxil
,
JNJ
,
drug shortages
,
FDA
,
EMA
Johnson & Johnson's Mishaps Mask A Great Business At A Reasonable Price
Seeking Alpha
Tue, 10/9/12 - 09:49 am
Tags:
JNJ
Pfizer Won't Get A Slap On The Wrist From The SEC
Seeking Alpha
Tue, 10/9/12 - 09:47 am
Tags:
Pfizer
,
SEC
,
GSK
,
JNJ
,
Merck
,
Novartis
J&J's $74 Value Hinges On Medical Devices Growth And Pharma Pipeline
Forbes
Mon, 10/8/12 - 08:35 pm
Tags:
JNJ
New Diabetes Drug Can Bolster J&J’s $74 Value
Trefis
Sat, 10/6/12 - 12:05 pm
Tags:
JNJ
,
diabetes
,
canagliflozin
,
type 2 diabetes
J&J's $74 Value Hinges On Medical Devices Growth And Pharma Pipeline
Forbes
Fri, 10/5/12 - 11:20 am
Tags:
JNJ
Former FDA chief says J&J broke law promoting Risperdal, Philly Inquirer says
Yahoo/Fly on the Wall
Thu, 10/4/12 - 10:55 am
Tags:
FDA
,
JNJ
,
Risperdal
Celgene's Pipeline Offers Catalysts Into 2013
Seeking Alpha
Thu, 10/4/12 - 10:43 am
Tags:
Celgene
,
JNJ
,
Bristol-Myers Squibb
,
Roche
,
ONYX Pharmaceuticals
,
Abraxane
,
Eli Lilly
J&J and Astellas Collaborate
Yahoo/Zacks
Thu, 10/4/12 - 10:42 am
Tags:
JNJ
,
Astellas
,
JAK inhibitors
,
ASP015K
,
rheumatoid arthritis
Opko's 4KScore Could Generate Over $1.8 Billion Annually
Seeking Alpha
Wed, 10/3/12 - 12:34 pm
Tags:
GSK
,
JNJ
,
OPKO Health
,
Merck
,
Novartis
,
Pfizer
,
Sanofi
,
prostate cancer
,
4Kscore
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tue, 10/2/12 - 10:05 am
Tags:
diabetes
,
JNJ
,
canagliflozin
,
Dapagliflozin
,
Bristol-Myers Squibb
,
AstraZeneca
Pages
« first
‹ previous
…
136
137
138
139
140
141
142
143
144
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.